BioSpace News Archive

Endo International plc (NASDAQ: ENDP) announced today that it completed the previously announced acquisition of BioSpecifics Technologies Corp., a commercial-stage biopharmaceutical company, for $88.50 per share in an all-cash transaction, for an estimated enterprise value of approximately $540 million (net of approximately $120 million in cash acquired).

Medicure Inc. (" Medicure " or the " Company ") (TSXV: MPH) (OTC:MCUJF), a cardiovascular pharmaceutical company, today announces that it has retained the services of Renmark Financial Communications Inc. (" Renmark ") to condu

Molecular diagnostics company Genetic Technologies Ltd (ASX: GTG; NASDAQ: GENE, the ‘Company’), announced today that they have entered into a three-year partnership agreement with mental health company, Taliaz, for the distribution rights of their PREDICTIX products in Australia, New Zealand and the USA (“Agreement”).

Qualigen Therapeutics, Inc. (Nasdaq: QLGN) announces that it has completed the recertification of its supply of AS1411, and has begun final formulation and filling for use in the Company’s proposed Phase 2a efficacy trials of AS1411 for the treatment of patients with COVID-19.

The company joins forces with Pepper Teigen, designer Zipeng Zhu, and Asian food brand Omsom to replace outdated “No MSG” signs with new “KNOW MSG” symbol

During the 62nd American Society of Hematology ( ASH ) Annual Meeting and Exposition, principal investigators from The US Oncology Network (The Network) and US Oncology Research will share detailed results from 30 studies covering topics that include Hodgkin lymphoma, multiple

“In the era of America’s deadly opioid crisis, cutting-edge pain therapeutics like THX-160 possess the potential to be a new and effective treatment option for pain patients, reducing the risks of opiate addiction.”

Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services, is a presenting sponsor and exhibitor at Clinical Trials in Rare Diseases taking place December 7-8 th , 2020. The presentation ‘Rare Disease Studies - Data Challenges & Solutions’, scheduled for December 8 th at 1:30 PM EST will feature Andrew Schachter, Axiom’s Founder & CEO and Kaitlyn Townsley, Axiom’s Associate Director of Product Innovatio

Imaging of proteins, cells, and tissues is critical to understanding health and disease. Today, the Chan Zuckerberg Initiative (CZI) announced nearly $32 million in funding to support biomedical imaging researchers, technology development, and the BioImaging North America international network of bioimaging facilities and communities.

CorTechs Labs Inc., creators of the first volumetric MRI application for clinical use, NeuroQuant, announced that it would begin operating under a new name, Cortechs.ai, starting today.